Literature DB >> 3172698

UKCCCR guidelines for the welfare of animals in experimental neoplasia.

P Workman1, A Balmain, J A Hickman, N J McNally, A M Rohas, N A Mitchison, C G Pierrepoint, R Raymond, C Rowlatt, T C Stephens.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3172698     DOI： 10.1258/002367788780746467

Source DB:  PubMed          Journal:  Lab Anim        ISSN： 0023-6772            Impact factor:   2.471


× No keyword cloud information.
  46 in total

1.  [18F]fluoromethyl-[1,2-2H4]-choline: a novel radiotracer for imaging choline metabolism in tumors by positron emission tomography.

Authors:  Julius Leyton; Graham Smith; Yongjun Zhao; Meg Perumal; Quang-De Nguyen; Edward Robins; Erik Arstad; Eric O Aboagye
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

2.  N-methylnitrosourea induced breast cancer in rat, the histopathology of the resulting tumours and its drawbacks as a model.

Authors:  M Perse; A Cerar; R Injac; B Strukelj
Journal:  Pathol Oncol Res       Date:  2008-11-05       Impact factor: 3.201

3.  Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.

Authors:  Peter Jantscheff; Vittorio Ziroli; Norbert Esser; Ralph Graeser; Jessica Kluth; Alena Sukolinskaya; Lenka A Taylor; Clemens Unger; Ulrich Massing
Journal:  Clin Exp Metastasis       Date:  2009-09-26       Impact factor: 5.150

4.  Guidelines for the welfare and use of animals in cancer research.

Authors:  P Workman; E O Aboagye; F Balkwill; A Balmain; G Bruder; D J Chaplin; J A Double; J Everitt; D A H Farningham; M J Glennie; L R Kelland; V Robinson; I J Stratford; G M Tozer; S Watson; S R Wedge; S A Eccles
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

5.  Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.

Authors:  Sonja J Heidorn; Carla Milagre; Steven Whittaker; Arnaud Nourry; Ion Niculescu-Duvas; Nathalie Dhomen; Jahan Hussain; Jorge S Reis-Filho; Caroline J Springer; Catrin Pritchard; Richard Marais
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

6.  Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo.

Authors:  P Babilas; V Schacht; G Liebsch; O S Wolfbeis; M Landthaler; R-M Szeimies; C Abels
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

7.  Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

8.  In vivo effects of rosiglitazone in a human neuroblastoma xenograft.

Authors:  I Cellai; G Petrangolini; M Tortoreto; G Pratesi; P Luciani; C Deledda; S Benvenuti; C Ricordati; S Gelmini; E Ceni; A Galli; M Balzi; P Faraoni; M Serio; A Peri
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

9.  The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.

Authors:  P Bhoopathi; C Chetty; M Gujrati; D H Dinh; J S Rao; S S Lakka
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

10.  Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth.

Authors:  Paula Sommer; Rachel L Cowen; Andrew Berry; Ann Cookson; Brian A Telfer; Kaye J Williams; Ian J Stratford; Paul Kay; Anne White; David W Ray
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.